CTAS vs MYO · P/E 51, rev $11.26B vs rev $21.8M
Cintas Corporation (CTAS) versus Myomo Inc (MYO) — a side-by-side from cached financials, not a winner call.
Cintas Corporation (CTAS) is a specialty business services company listed on US.
Myomo Inc (MYO) is a medical devices company listed on AMEX.
Latest reported CTAS revenue for 2026-05-31 was $11.26B. Net income was $2.00B. Revenue was up 8.9% from 2025-05-31 to 2026-05-31. CTAS currently screens at market cap $89.01B and trailing P/E 51.3.
Latest reported MYO revenue for 2026-06-30 was $21.8M. Net income was -$7.0M. MYO currently screens at market cap $57.6M.
CTAS currently screens at market cap $89.01B and trailing P/E 51.3. MYO currently screens at market cap $57.6M.
Not investment advice. Open the CTAS and MYO stock pages for the full models.
Not investment advice.